COVID-19 UPDATE | 26 March 2020
We have made the difficult decision to pause all active calls.
We understand that this will be a huge disappointment to those of you that have already spent time developing projects and drafting applications. However, we recognise that many of you will be facing unknown delays as a result of lab closures and project partners will potentially, at least in the short term, be prioritising their focus elsewhere in response to the crisis.
We need to have an understanding of what is required for us to complete existing projects – and what will be possible to deliver – before confirming the start of new projects.
However, our Technology Innovation Managers are still on hand to work with you to understand your technology development and innovation needs and identify the right partners within our regions to help you build a successful collaboration for the future – click here to view their profiles and obtain their contact details.
Our Industry-led Proof of Feasibility call is a new package of support available for small and medium-sized enterprises to develop new medical technologies by connecting to academic capability within our partner universities.
We can help businesses to access the specialist expertise needed by teaming up with the relevant Grow MedTech researchers to de-risk and advance the development of new medical technologies in order to build confidence for further investment.
Proof of Feasibility awards of up to £20,000 for a maximum duration of 6 months are available to support industry-led medtech innovation projects, which fit with the scope of the award, and where proof of market and the clinical need have already been established.
Our Technology Innovation Managers can work with you to understand your technology development and innovation needs and identify the right capability within our partner universities to help you build a successful collaboration. We can help you connect with the academic expertise you need to move your technology forward.
All projects must be based on:
- Collaboration (industry with academia)
- Co-investment (industry match*)
- Industry needs
- Global market opportunity
- Clear clinical drivers, patient benefits
- Expertise within a Grow MedTech University
- Developing a commercially viable product
*30% micro and small companies, 40% medium companies of the total project costs (in-kind and direct cash paid to the university partner).
Grow MedTech supports the development of medical devices, including materials and software, but does not support the development and discovery of pharmaceuticals.
All applications should have a strong emphasis on patient benefit with plans for patient and public involvement and strong clinical engagement is encouraged.
This call does not directly fund industry/commercial organisations.
How to apply
Click here for full call guidance, scope and eligibility. Application forms can be provided by and should be co-developed with a Grow MedTech Technology Innovation Manager – click here to view their profiles and obtain their contact details.